| |
Full scenario vs. restricted scenario 1
|
Restricted scenario 2 vs. 1
|
Restricted scenario 2 vs. 3
|
Restricted scenario 2 vs. 4
|
Restricted scenario 4 vs. 3
|
|---|
|
Overviews for which Cochrane SRs examined all relevant intervention comparisons
|
|
Bronchiolitis
|
More
|
Same
|
Same
|
Same
|
Same
|
|
Croup
|
Same
|
Same
|
Same
|
Same
|
Same
|
|
Gastroenteritis
|
More
|
Same
|
More
|
Same
|
More
|
|
Overviews for which Cochrane SRs did not examine all relevant intervention comparisons
|
|
Acute asthma
|
More
|
More
|
More
|
Same
|
More
|
|
Acute otitis media
|
More
|
More
|
Similar
|
Unknown
|
Unknown
|
|
Eczema
|
More
|
More
|
More
|
Unknown
|
Unknown
|
|
Procedural sedation
|
More
|
Unknown
|
Unknown
|
Unknown
|
Unknown
|
- Full scenario: include all Cochrane and non-Cochrane SRs; restricted scenario 1: include only Cochrane SRs; restricted scenarios 2–4: include all non-overlapping SRs, and in the case of overlapping SRs include the Cochrane SR (restricted scenario 2), the most recent SR (restricted scenario 3), or the highest quality SR (restricted scenario 4). “More” means that more outcome data were included in the first-listed vs. second-listed scenario; “same” means that the same amount of outcome data were included in both scenarios; “similar” means that the same amount of outcome data were included in both scenarios, but the breakdowns differed across primary, secondary, and adverse effects outcomes; “unknown” means that we were unable to calculate the amount of outcome data
